have followed MSB for a while and not a current holder (will be soon though). This announcement is fantastic and backs up recent work done by MSB. two things are certain
- this will generate global news and interest in this stock - the results are significant
- Remestemcel-L use for ARDS patients will increase dramatically now based on compassionate grounds.
well done to holders and MSB. I see the previous pattern for MSB is for the SPP to retrace after a positive announcement, but this announcement and environment is different IMO. the share price should sharply increase over coming days and weeks, this announcement is a globally significant announcement (even based on small numbers). great work!
have followed MSB for a while and not a current holder (will be...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |